Cytomegalovirus-induced Hemorrhagic Colitis in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront Therapy

Dasatinib is a kinase inhibitor indicated for the treatment of newly diagnosed adults with Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML) in chronic phase and accelerated (myeloid or lymphoid blast) phase, and CML with resistance or intolerance to prior therapy including imati...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Clin Med Insights Case Rep
Main Authors: Yassin, Mohamed A, Nashwan, Abdulqadir J, Soliman, Ashraf T, Yousif, Anil, Moustafa, Afra, AlBattah, Afaf, Mohamed, Shehab F, Mudawi, Deena S, Elkourashy, Sarah, Asaari, Deena-Raiza, Gutierrez, Hope-Love G, Almusharaf, Mohamed, Hussein, Radwa M, Moustafa, Abbas H, Derhoubi, Hatim El, Boukhris, Sarra, Kohla, Samah, AlDewik, Nader
פורמט: Artigo
שפה:Inglês
יצא לאור: Libertas Academica 2015
נושאים:
Case Report
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4554353/
https://ncbi.nlm.nih.gov/pubmed/26379451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CCRep.S25327
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים